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A case of lymphocytic choriomeningitis virus (LCMV)
infection led to investigation of the reservoir. LCMV was
detected in mice trapped at the patient’s home, and 12 iso-
lates were recovered. Genetic analysis showed that human
and mouse LCMVs were identical and that this LCMV
strain was highly divergent from previously characterized
LCMV.
L
ymphocytic choriomeningitis virus (LCMV) belongs to
the genus Arenavirus in the family Arenaviridae. Mus
musculus mice constitute the reservoir of LCMV in nature
(1), but hamsters can also carry the virus. Humans usually
become infected through direct contact with infected
rodents or by inhaling infectious rodent excreta or secreta
during occupational exposure (laboratory workers, rodent
sellers) or when caring for rodents as pets. Although
LCMV infection is usually asymptomatic or mild and self-
limiting, it can be severe and manifest itself as meningitis
and encephalitis (2,3). Infection during pregnancy may
cause abortion or congenital malformations (4). In 2003
and 2005, two episodes of infections occurred in 2 groups
of 4 recipients of solid-organ transplants; 7 of the 8 patients
died (5). Although laboratory evidence of LCMV infection
was obtained from the 8 organ recipients and from the ham-
ster handled by donor 2, no laboratory evidence of infection
could be obtained from specimens from both donors.
Therefore, evidence for transmission from donor to recipi-
ent was mainly based on epidemiologic data and on the
genetic identity of the virus detected in transplanted organs.
The Study
A 5-year-old boy was admitted to the neuropediatric
ward of a Marseille University hospital in August 2004 for
aseptic meningitis. Forty-five days later, he was admitted
again with fever and meningitis, and his condition rapidly
deteriorated with encephalitis and hydrocephalus develop-
ing as described (6). LCMV infection was suspected on the
basis of  the clinical signs and a detailed interview of the
mother, in which she indicated that “the house was invad-
ed with mice.” LCMV was diagnosed based on serocon-
version and positive PCR results with confirmatory
sequence data (6).
Because M. musculus is the natural host of LCMV, the
Public Health Office of Marseille organized a trapping
campaign in the vicinity of the patient’s house, which
resulted in the capture of 20 mice (M. musculus) with glue
traps. Most were alive when they were received at the lab-
oratory. They were humanely killed and dissected; kid-
neys, lungs, heart, spleen, and liver were placed
individually in 1.8-mLtubes and stored at −80°C. For each
animal, 1 kidney was homogeneized as previously
described (7). Recovered material was used either for virus
isolation on Vero cells (detailed protocol available on
request) or for total RNA isolation with the EZ1 Virus
Mini Kit v2.0 on the BioRobet EZ1 Workstation
(QIAGEN SA, Courtaboeuf, France) and eluted in 75 µL
final volume. A total of 10 µL was tested for LCMV RNA
as described herein. Three different PCR assays, targeting
the nucleoprotein gene, were used. System 1 was a nested
reverse transcription–PCR (RT-PCR) that used primers
1817V-LCM (5′-AIATGATGCAGTCCATGAGTGCA
CA) and 2477C-LCM-3′ (5′-TCAGGTGAAGGRTGGC
CATACAT-3′) for the first round and primers 1902V-LCM
(5′-CCAGCCATATTTGTCCCACACTTT-3′) and 2346C
-LCM (5′-AGCAGCAGGYCCRCCTCAGGT-3′) for the
second round. These primers were derived from those
reported by Bowen et al. (8,9) and designed from the align-
ment of LCMV sequence data retrieved from GenBank.
System 2 was a real-time RT-PCR with primers
LCM_TM_NP1 (5′-TCATGTGGCARRATGTTGTG-3′)
and LCM_TM_NP2 (5′-AAAAAGAAIAARGARAT
CACCCC-3′) together with a FRET probe LCM_
MAR_NP (5′-ATGATGCAATCCATAAGTGCGCAGT-
3′). System 3 was a SYBR Green real-time RT-PCR based
on primers LCM_SG_NP1 (5′-TTRTCRTCYCTYYTYT
CYTTYCTCAT-3′) and LCM_SG_NP2 (5′-CAGGTRA
CYTTYGARAAITRRAGRAA-3′). The 3 detailed RT-
PCR protocols are available on request. Human cere-
brospinal fluid (CSF) samples and mouse specimens were
added to Vero cells. After incubation at 37°C for 7 days,
cells were tested for LCMV RNA by PCR with PCR
system 1.
Results of PCRs and virus isolation are presented in
the Table. Criteria to consider that samples contained
LCMV RNA or LCMV were 1) virus isolation or 2) posi-
tive PCR results for at least 2 systems. Genetic analyses
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France and phylogenetic reconstruction were based on sequences
flanked by primers 1902V-LCM and 2346C-LCM. These
primers amplified a 445-bp PCR product (primers includ-
ed) and provided a 400-nt sequence (primers excluded)
used for analysis. Nucleotide alignments were performed
by using ClustalX 1.81 with default parameters (10).
Alignments included the 16 sequences determined in this
study and homologous LCMV sequences retrieved from
the GenBank database. Phylogenetic analysis was per-
formed with the Jukes-Cantor algorithm for distance cal-
culation and the neighbor-joining method for cluster
reconstruction with the MEGA 2.0 program (11). The
robustness of nodes was tested by 500 bootstrap
pseudoreplications.
As shown in the Table, the 2 human CSF specimens
and 14 of 20 mouse samples were PCR positive. The 2
sequences obtained from human CSF specimens were
100% identical to each other. The 14 sequences represent-
ing mouse kidney specimens were almost identical (98.5%
nucleotide identity) (Figure). Comparison of human and
mouse sequences showed genetic identity >98% at the
nucleotide level (Figure). This high level of similarity sug-
gests that human LCMV infection was caused by transmis-
sion from the mice. All 16 sequences determined in this
study either from human or rodent material had 12%–13%
nucleotide heterogeneity when compared with LCMV
sequences deposited in the GenBank database and with the
sequence of LCMV strain manipulated in the laboratory,
thus excluding the possibility of laboratory contamination.
Finally, a total of 12 strains were isolated from Vero cells;
1 was selected to be characterized by full-length genome
sequencing (GenBank accession nos. DQ286931 and
DQ286932 for S and L RNA sequences, respectively).
Conclusions
Apart from isolated cases or outbreaks of LCMV
infection associated with direct contact with laboratory
rodent colonies, evidence for direct epidemiologic links
between human cases and wild mice was based on virus
isolation and antigenic relationships. Evidence based on
genetic analysis of human and mice strains was not previ-
ously reported. Field investigations, conducted between
LCMV discovery in 1933 and World War II, to search for
a source of human cases, reported virus isolation from gray
mice (M. musculus) trapped in or in the close vicinity of
patient’s house. The strains isolated from mice and humans
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indisputable evidence of genetic identity was not pro-
duced. To our knowledge, this is the first report of human
LCMV infection linked to wild mice as assessed by genet-
ic evidence. Rates of infection by LCMV in wild rodent
colonies reported in the literature (12,13) are of similar
magnitude as the 70% rate found in this study. Such high
rates can explain how clusters of human cases are likely to
result from substantial exposure to infectious aerosols. In
our study, the mother of the patient was negative for
LCMV antibodies; other members of the family refused to
undergo serologic testing. Altogether, these sequence data
and the evidence of virus isolation from mice provide
strong evidence that the LCMV human case resulted from
infection with a virus carried by mice infesting the
patient’s home through direct or indirect contact with
mouse excreta. In the case reported by Fischer et al. (5),
although the LCMV cause is not in doubt, the lack of lab-
oratory evidence (serology, immunohistochemical stain-
ing, PCR, virus isolation) of LCMV infection in both
donors is intriguing. 
This study, together with recent reports of LCMV
infection cases, raise concerns regarding the low level of
knowledge of LCMV epidemiology that may reflect the
fact that LCM was historically more prevalent in rural set-
tings, and that it could be decreasing in the urban popula-
tions of industrialized countries. However, the growing
proportion of persons living below the poverty threshold in
large European and North American cities may recreate
conditions compatible with the increased urban circulation
of mice, and therefore increase the likelihood of rodent-
associated diseases.
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